Arena Pharmaceuticals (ARNA) down on downbeat Q4 results

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares dropped 5.4% to $4.05 after the company reported downbeat financial results for the fourth quarter. Share volume was 3.7 million, compared to an all-day average of 8.4 million.